Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

Conditions:   Acute Myeloid Leukemia, in Relapse;   Myelodysplastic Syndromes Intervention:   Drug: CB-5339 Sponsor:   Cleave Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials